Author: McEachern, Jennifer A.; Bingham, John; Crameri, Gary; Green, Diane J.; Hancock, Tim J.; Middleton, Deborah; Feng, Yan-Ru; Broder, Christopher C.; Wang, Lin-Fa; Bossart, Katharine N.
Title: A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats Cord-id: 7c6o674b Document date: 2008_7_23
ID: 7c6o674b
Snippet: Abstract Nipah virus (NiV) and Hendra virus (HeV) are closely related deadly zoonotic paramyxoviruses that have emerged and re-emerged over the last 10 years. In this study, a subunit vaccine formulation containing only recombinant, soluble, attachment glycoprotein from HeV (sGHeV) and CpG adjuvant was evaluated as a potential NiV vaccine in the cat model. Different amounts of sGHeV were employed and sG-induced immunity was examined. Vaccinated animals demonstrated varying levels of NiV-specific
Document: Abstract Nipah virus (NiV) and Hendra virus (HeV) are closely related deadly zoonotic paramyxoviruses that have emerged and re-emerged over the last 10 years. In this study, a subunit vaccine formulation containing only recombinant, soluble, attachment glycoprotein from HeV (sGHeV) and CpG adjuvant was evaluated as a potential NiV vaccine in the cat model. Different amounts of sGHeV were employed and sG-induced immunity was examined. Vaccinated animals demonstrated varying levels of NiV-specific Ig systemically and importantly, all vaccinated cats possessed antigen-specific IgA on the mucosa. Upon oronasal challenge with NiV (50,000TCID50), all vaccinated animals were protected from disease although virus was detected on day 21 post-challenge in one animal. The ability to elicit protective systemic and mucosal immunity in this animal model provides significant progress towards the development of a human subunit vaccine against henipaviruses.
Search related documents:
Co phrase search for related documents- absolute level and acute respiratory syndrome: 1, 2, 3, 4
- acute respiratory distress syndrome and adjuvant control: 1, 2
- acute respiratory distress syndrome and adrenal gland: 1
- acute respiratory syndrome and adjuvant control: 1, 2, 3
- acute respiratory syndrome and adjuvant cpg motif: 1, 2
- acute respiratory syndrome and adjuvant receive: 1, 2
- acute respiratory syndrome and adrenal gland: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute respiratory syndrome and adrenal gland bladder: 1
Co phrase search for related documents, hyperlinks ordered by date